Multiple sclerosis synergistic phyto-nutraceutical composition
AssigneeJose Angel Olalde Rangel
InventorJose Angel Olalde Rangel
Life of this patent
Estimating the term…
Abstract
A Phytoceutical composition for the prevention and treatment of Multiple Sclerosis (MS) and symptoms is provided. A specific combination of extracts of plants and nutraceuticals is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.
Claims1
A method of treating multiple sclerosis comprising administering an effective amount of the composition, comprising 22 mg Panax ginseng, 22 mg Panax quinquefolius, 54 mg Pfaffia paniculata, 3 mg Rhaponticum carthamoides, 22 mg Rhodiola rosea, 4 mg Schizandra chinensis, 54 mg Agaricus blazei, 54 mg Andrographis paniculata, 54 mg Astragalus membranaceus, 54 mg Coriolus versicolor, 16 mg Echinacea spp., 190 mg Ganoderma lucidum, 54 mg Grifola frondosa, 6 mg Hericium erinaceus, 54 mg Lentinus edodes, 5 mg Petiveria alliacea, 27 mg Tabebuia avellanedae, 27 mg Uncaria tomentosa, 54 mg Coriandrum sativum L., 54 mg Equisetum arvense, 27 mg Hydrastis Canadensis, 16 mg Hydrocotyle asiatica, and 27 mg Smilax regelii.
Dependencies are inferred from the claim text.